Beyond Royalties

As AI changes how companies build and deliver products, strategically positioned patents can protect more than a revenue stream. They can strengthen a company’s role in the market itself.

A company can hold a small share of an industry’s sales and still influence how its largest participants compete. It may own rights covering a critical feature, a production method, or an architecture that connects products and services. Those rights can affect what competitors offer, which partners they need, and where profits accumulate.

This is why a royalty forecast can miss much of a patent estate’s strategic value. It measures income from granting access. A strategic assessment also considers the market share an owner can defend, the complementary revenue it can earn, and the choices it can retain as an industry evolves. The value depends on the rights and on the business positioned to use them.

The distinction is becoming more consequential in enterprise AI. If software functionality becomes easier to reproduce and agents move work across applications, durable advantage may increasingly depend on the architecture through which that work is authorized, coordinated, and executed. For business leaders and investors, patent strategy therefore belongs alongside product strategy, partnerships, and capital allocation.

Seven mechanisms connect patent ownership to competitive value

A commercially coherent estate can affect competition through several mechanisms. Their importance varies by industry, and their benefits often overlap.

Patents confer rights to exclude within their scope. Commercial results depend on relevant coverage, enforceability, and execution. ^[1]

Three cases reveal where the value appears

Masimo shows how focused rights can influence a much larger competitor. In October 2023, the U.S. International Trade Commission issued an exclusion order covering infringing Apple wearable devices with pulse-oximetry functionality. In August 2025, Apple announced a redesigned Blood Oxygen feature for affected U.S. models, with calculation and display on a paired iPhone. The strategic consequence was a change in product configuration and availability. The case demonstrates leverage over a valuable feature; it does not establish a corresponding gain in Masimo’s market share. ^{[2, 3]}

Qualcomm shows how patent negotiations can connect to supply relationships. Its April 2019 settlement with Apple included a payment, a six-year license, and a multiyear chipset supply agreement. Intel announced its planned exit from 5G smartphone modems the same day, citing the absence of a clear path to profitability. The episode linked licensing, product supply, and market structure. It does not establish that patents alone caused Intel’s exit, but it illustrates why the value of a settlement can extend well beyond royalty income. ^{[4, 5]}

Keurig shows what changes when protection expires. Green Mountain disclosed that two K-Cup patents expired in September 2012 and that third parties had launched competing products. Management expected unlicensed packs to represent roughly 5% to 15% of system demand over the following years and identified potential pressure on margins. These were contemporary expectations, not measured outcomes. The broader lesson is that a valuable installed base does not permanently reserve the economics of its consumables for the company that created it. ^[6]

The economic footprint extends beyond patent owners

Official studies show the scale of patent-intensive activity, although they do not measure control by large estates.

The U.S. measure covers utility patent-intensive industries. Definitions, periods, and denominators differ, so the figures cannot be averaged into a worldwide control estimate. Indirect influence extends through suppliers and downstream users of patented communications, computing, equipment, and medical technologies. Across all IP types, U.S. IP-intensive industries supported 49.6 million direct jobs and 16.2 million additional supplier jobs in 2024. That illustrates supply-chain reach, not patent-only output. ^[7]

The distinction matters for valuation. A technology may enable substantial downstream activity without giving its patent owner control over all that activity or a claim to all its revenue. Economic exposure, enforceable coverage, and realizable value must be assessed separately.

Agentic AI shifts attention toward deployment architecture

The strategic question in AI is moving beyond which model or application performs best. As agents complete work across enterprise systems, value can migrate toward the architecture that determines what they may access, whose authority they carry, how they coordinate, and how their actions are governed.

Gartner estimates that up to $234 billion of enterprise application spending could be exposed to agentic arbitrage through 2030, equivalent to roughly 20% of enterprise application SaaS spending by that year. Its premise is that agents can complete tasks across systems while reducing reliance on traditional interfaces. The forecast points to a potential redistribution of software economics, not a guaranteed loss of spending. ^[10]

Deployment remains demanding. Gartner separately predicts that more than 40% of agentic AI projects will be canceled by the end of 2027 because of cost, unclear value, or inadequate risk controls. This raises the commercial importance of reliable integration and governance. It does not, by itself, establish that the market will consolidate around a particular provider or patented architecture. ^[11]

For patent owners, the opportunity is to protect commercially important methods that remain useful as individual models and applications change. Early filings can matter when their disclosures support claims relevant to later implementations. Early dates alone are insufficient: claim scope, validity, remaining life, and practical alternatives determine the strength of the position.

Strong Force illustrates a strategy built around convergence

Strong Force Innovation Portfolios describes its approach as anticipating the intersection of technologies before products arrive. The company reports nearly 1,000 patent assets and more than 10,000 innovations focused on AI’s convergence with other technologies. Its strategic proposition is that rights developed around interconnected business systems can become relevant across multiple industries as those systems adopt AI. ^[12]

Viewed through this lens, the estate’s potential value is not confined to collecting fees from individual applications. A buyer could evaluate how relevant rights strengthen its own offerings, improve negotiating positions, enable partners, or support participation across competing platforms. Breadth creates more possible applications; depth around commercially important functions determines how consequential those applications may be.

Strong Force’s April 2025 agreement with SIM IP illustrates another route to value. The announced arrangement addressed development, sale, and licensing of selected industrial-technology assets focused on Europe, with revenue sharing. It demonstrates that selective monetization and a broader strategic agenda can coexist. It does not establish a guaranteed valuation floor for the remaining estate. ^[13]

Translate strategic position into incremental economics

The valuation question is what changes for a particular owner. Two percentage points of additional share in a $100 billion annual market would represent $2 billion of revenue. At an illustrative 25% incremental operating margin, that would generate $500 million in annual pretax profit. The calculation shows why competitive position can matter more than a standalone royalty forecast. It becomes an estate valuation only after testing attribution, duration, costs, taxes, and risk, without counting the same benefit twice.

A leadership agenda for strategic patent estates

Executives and investors can turn the broader thesis into a decision process through five questions.

Where does ownership change the competitive outcome? Begin with specific products, workflows, customers, and profit pools. Identify which rights affect an actual decision to buy, build, partner, enter, or redesign. A large market is relevant only when coverage connects to commercially important activity.

How difficult is substitution in practice? Examine viable alternatives across the estate, not simply the ease of avoiding one claim. A coherent portfolio may cover multiple routes to the same commercial result. Related filings can also share weaknesses, so density must be demonstrated rather than inferred from asset counts.

Which participation model creates the most value? Reserving rights can support differentiation; broad licensing can expand adoption and complementary sales. The right choice depends on where the owner earns and what partners need to invest. Existing licenses, standards commitments, and competition law shape the available options.

What is the value to this owner compared with its alternatives? Compare acquisition with licensing, substitution, and proceeding without the rights. Combine technical and legal analysis with business-unit economics. The same estate can have different values for buyers with different customers, products, and execution capabilities.

Which decisions preserve future choices? Evaluate licenses, joint ventures, and asset sales against both their immediate return and the rights a future owner would retain. In a strategic sale process, a small transaction can have an outsized effect if it commits commercially important applications or limits transferability.

The most important asset may be the ability to shape participation as a market develops. A strong estate can help an owner protect differentiated products, enable a wider ecosystem, and capture value across activities performed by others. For Strong Force and its potential strategic buyers, the investment case is most compelling when those possibilities are translated into specific competitive advantages and incremental cash flows.

Sources

1. USPTO. Managing a patent.
2. USITC. Final determination, Investigation 337-TA-1276, October 26, 2023.
3. Apple. Update on Blood Oxygen, August 14, 2025.
4. Apple. Qualcomm settlement, April 16, 2019.
5. Intel. Exit from 5G smartphone modems, April 16, 2019.
6. Green Mountain Coffee Roasters. Fiscal 2012 Form 10-K, competition and patent disclosures.
7. USPTO. Intellectual property and the U.S. economy in 2024, August 2026.
8. EPO and EUIPO. IP and innovation in European sectors, January 2026, Table 2.
9. China NBS and CNIPA. Patent-intensive industries in 2024, December 31, 2025.
10. Gartner. Enterprise application spending exposed to agentic AI, July 1, 2026.
11. Gartner. Agentic AI project cancellation forecast, June 25, 2025.
12. Strong Force Innovation Portfolios. Company overview, accessed October 7, 2026.
13. SIM IP. Strong Force strategic relationship, April 24, 2025.